Technology landscapes for medical devices
Technology landscaping in medical device innovation is a strategic process that involves systematically gathering, analysing, and interpreting information about current and emerging technologies within the medical device sector.
These landscapes help identify trends, opportunities, challenges, and strategic directions for innovation in medical devices.
In the medical device world, technology landscaping involves developing multiple interconnected landscapes, each providing crucial insights into different aspects of the industry.
By systematically analysing these landscapes, innovators and manufacturers can make informed strategic decisions, drive innovation, and stay competitive in the rapidly evolving medical device market.
Many different types of technology landscapes are used throughout the medical device lifecycle:
The technological landscape focuses on current and emerging technologies relevant to medical devices. Broad technological landscaping allows companies to leverage cutting-edge technologies, anticipate future trends, and invest in promising innovations.
- Emerging Technologies: Advances in computer science, material science, bioengineering, electronics and electrical engineering.
- Technology Maturity: Technology readiness levels from research to commercialisation.
- Patents and Innovations: Analysis of patents to identify innovative technologies and potential IP conflicts.
- R&D Trends: Areas of high research activity and investment. Technological landscapes may also be narrowly focused when used to generate evidence supporting research and feasibility studies of a specific medical device concept. A technological landscape is usually the first landscape that a medical device innovator develops as part of early research activities.
The IP landscape involves analysing patents and other intellectual property to understand innovation trends and competitor positions and protect proprietary technologies. A robust IP landscape protects innovations, avoids legal issues, and identifies technology licensing and collaboration opportunities. Given the central role of IP in the medical device industry, these landscapes are often a priority for medical device manufacturers to establish and maintain.
An IP landscape forms the foundation of a company IP management strategy through:
- Patent Mapping and Analysis: Review of patent filings to:
- Identify innovation trends, hotspots and gaps in IP coverage.
- Identify prior art that impacts the ability to protect an innovation.
- Establish Freedom-to-Operate (FTO) for a medical device product concept.
- Identify third-party IP that may be required to commercialise a medical device.
- Uncover potential infringements.
- Identify existing and emerging competitors and partners for development or commercialisation.
- IP Strategies: Developing tactics to secure and defend IP, including patent applications and litigation, trademarks, design rights, copyrights and trade secrets.
- Licensing Opportunities: Potential for creating revenue through licensing IP to other organisations.
Patent databases are comprehensive repositories that contain detailed information about patents, including their status, claims, inventors, and associated legal events. These databases are essential for inventors, companies, researchers, and legal professionals to access and analyse patent information for research and development, competitive analysis, intellectual property management, and legal proceedings.
The market landscape provides insights into market dynamics, including demand, supply, pricing, and distribution channels for medical devices. Understanding the market landscape helps identify growth opportunities, optimise product positioning, and plan market access strategies.
- Market Segmentation: Analysing the division of the market into segments based on device type, application, customer segment, and geography. Medical device markets are complex, often segmented into numerous target markets, which can change based on local conditions.
- Market Size and Growth: Current market size and projected growth rates.
- Demand Drivers: Factors driving demand include patient demographics, epidemiology, healthcare spending and reimbursement policies. Market dynamics often depend on many factors, some outside the health system.
- Distribution Channels: Pathways for launching products, including direct sales, distributors, and eCommerce.
The competitive landscape examines the activities, strengths, weaknesses and strategies of existing and potential competitors in the market. Analysing the competitive landscape helps identify market gaps, benchmark against competitors, and develop strategies to gain a competitive edge:
- Market Share: A competitive landscape analyses the major existing players and their market positions, defined by market segment or geography. It is also helpful in identifying emerging competitors and their market entry strategies.
- Product Portfolios: A competitive landscape should compare product or service offerings and technological capabilities and analyse the existing portfolio and the product pipeline.
- Strategic Initiatives: Tracking competitor investments in R&D and innovation, including IP portfolio strengths and weaknesses and business development activities through mergers and acquisitions (M&A), partnerships (in development, distribution, marketing), and licensing agreements.
The competitive landscape is often represented through a SWOT Analysis: strengths, weaknesses, opportunities, and threats of competitors.
The socio-economic landscape examines the broader societal, economic and environmental factors that impact the medical device industry. Understanding the socio-economic landscape helps tailor products to market needs, align with policy changes, and anticipate shifts in healthcare demand. As with market landscapes, many factors influencing the socio-economic landscape are not directly within the control of health systems.
- Demographic Trends: Changing patient demographics, urbanisation, and changes in disease patterns.
- Economic Conditions: Economic growth, healthcare expenditure, and reimbursement coverage.
- Healthcare Policies: Government policies affect healthcare delivery, medical device use, and reimbursement.
- Cultural Factors: Patient preferences, lifestyle changes, and health awareness.
- Environmental Factors: Climate change interventions and net-zero policies, waste management requirements.
The investment landscape looks at the funding environment, including sources of capital and investment trends in the medical device industry. A clear view of the investment landscape helps secure funding, identify strategic partners, and understand the industry’s financial trends.
- Funding Sources: Venture capital, private equity, government grants, and corporate investments.
- Investment Trends: Identify technologies or device types attracting significant investment.
- Mergers and Acquisitions: Recent M&A activities and their impact on the market.
- Funding Opportunities: Availability of grants, loans, and other financial support for R&D and commercialisation. Funding databases are specialised platforms or repositories that provide comprehensive information on various funding sources available to researchers, entrepreneurs, businesses, and non-profit organisations. Information on past recipients and funded projects to provide insights into trends in funding and who has the money.
The regulatory landscape encompasses the policies, regulations, and standards governing medical device development, approval, and commercialisation. Understanding the regulatory landscape ensures compliance, reduces time to market, and helps anticipate regulatory changes that could impact device development and commercialisation.
- Regulatory Authorities: Review requirements and guidance documents from relevant regulatory bodies.
- Approval Processes: Analyse conformity assessment pathways and associated timelines and costs.
- Compliance Standards: Identify relevant international standards.
The reimbursement landscape for medical devices encompasses the policies, processes, and stakeholders involved in determining how and when healthcare providers and patients are compensated for using medical devices. Successful navigation requires a thorough understanding of the time to market and helps anticipate stakeholder expectations.
- Health systems: Understanding the type and organisation of health systems, including governance, financing, healthcare delivery mechanisms, and health technology use.
- Stakeholders: Identify stakeholders and analyse their priorities and expectations.
- Reimbursement: Identify reimbursement coverage mechanisms, policies and processes.
- Evidence requirements: Analyse the evidence requirements for gaining reimbursement coverage and gaps with regulatory evidence requirements.
Tips for technology landscaping
Landscaping is one of the most valuable tools available to a medical device innovator. All healthcare products and services are developed based on evidence. As a result, a lot of evidence is already available on diseases and conditions, existing technologies and the health systems where devices are used. Much of this evidence is easily accessible to anyone with an internet connection, and is often open access. This makes technology landscaping one of the most cost-effective evidence-synthesis tools for medical device innovators. It takes time and a modicum of expertise in learning how to read and interpret different types of evidence.
The disadvantage of technology landscaping is that it can take a lot of time. Some helpful tips include:
- Developing processes that enable technology landscapes to evolve through the development lifecycle.
- Using an iterative approach to landscaping that starts with high-level analysis during ideation and conception and becomes more targeted through research and feasibility.
- Starting with processes that are compliant with regulatory and reimbursement requirements.
- Investing strategically in software tools that help manage vast amounts of information.
Resources
MedDev Central Academy:
MedDev Central Knowledge Hub:
Benefit-Risk Analysis: The comparison of a medical device’s benefits to its associated risks, often used in regulatory decision-making.
Clinical Context: The specific medical conditions, patient populations, and healthcare settings in which a device is intended to be used, influencing its design, functionality, and regulatory requirements.
Clinical Evaluation: A methodologically sound ongoing procedure to collect, appraise, and analyse clinical data about a medical device and to verify its safety and performance, including its clinical benefits. Also see Clinical Investigation.
Clinical Guideline: A systematically developed statement to assist healthcare practitioners and patients in making decisions about appropriate healthcare for specific clinical circumstances.
Conception The initial phase of product development, during which an idea is generated and conceptualised into a feasible product design, considering market needs, technical feasibility, potential benefits, and risks.
Equivalency: Demonstrating that a new device is as safe and effective as an already marketed device by comparing its technical and functional characteristics.
Healthcare Professional: An individual trained and licensed to provide medical care, treatment, and advice to patients, encompassing a range of roles such as physicians, nurses, pharmacists, and allied health professionals.
Ideation: The creative process of generating, developing, and communicating new ideas.
Manufacturer: A legal entity that designs, produces, assembles, or labels a medical device with the intention of placing it on the market.
Medical Device: An instrument, apparatus, implement, machine, appliance, implant, reagent for in vitro use, software, material, or other similar or related article intended for diagnosis, prevention, monitoring, treatment, or alleviation of disease. Each regulatory authority has a formal definition of a medical device, which should be referred to for regulatory compliance.
Payer: An entity or organisation, such as an insurance company or government agency, responsible for reimbursing or funding healthcare expenses related to using health technologies.
Post-Market Surveillance (PMS): The proactive collection and review of experiences and data related to a device after it has been released onto the market to ensure continued safety and performance.
Predicate Device: An existing on-market device that provides a basis for comparison or reference in demonstrating substantial equivalence for regulatory purposes.
Regulation: The rules, laws, standards, and requirements set by regulatory authorities to ensure the safety, efficacy, and quality of devices intended for medical use.
Regulatory Authority: An official body overseeing and enforcing laws, regulations, and standards within a specific industry or sector to ensure compliance and protect public interests. Also known as a Regulatory Authority. Also see Competent Authority and Notified Body.
Regulatory Submission: The formal process of submitting documentation and data to regulatory authorities for review and approval to market or sell the device within a specific jurisdiction.
Reimbursement: The process of receiving payment from insurers, government health programs, or healthcare facilities for the use of medical devices in patient care.
Standard: A document that provides guidance, requirements, or specifications established by regulatory bodies, industry organisations, or international consensus groups.
State-of-the-art (SotA): The current knowledge or good practice acceptable in the medical devices industry.
Systematic Review: A structured and comprehensive synthesis of research studies that aims to identify, select, assess, and summarise the findings of all relevant individual studies on a particular topic.